サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1105652

in vivo CROの世界市場規模調査：タイプ別、GLPタイプ別、適応症別、地域別予測（2022年～2028年）

Global In Vivo CRO Market Size study, by Type, By GLP Type, By Indication and Regional Forecasts 2022-2028
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
in vivo CROの世界市場規模調査：タイプ別、GLPタイプ別、適応症別、地域別予測（2022年～2028年）
出版日: 2022年07月05日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のin vivo CROの市場規模は、2021年に約39米ドルとなり、予測期間（2022年～2028年）中に8.20％以上のCAGRで成長すると予測されています。

高度な医薬品への需要の高まり、CROの世界標準の導入、大手製薬会社の研究開発のアウトソーシング化は、in vivo CRO市場の拡大の要因となっています。しかし、製薬会社の臨床試験や前臨床試験のアウトソーシング傾向の増加が、市場の成長を抑制しています。

当レポートでは、世界のin vivo CRO市場について調査分析し、市場力学、業界分析、市場分析、競合情報など、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 世界のin vivo CRO市場の定義と範囲

第3章 世界のin vivo CRO市場力学

  • in vivo CRO市場の影響分析（2020年～2028年）

第4章 世界のin vivo CRO市場の業界分析

  • ポーターのファイブフォースモデル
  • PEST分析
  • 投資採用モデル
  • アナリストの推奨事項と結論
  • 最高の投資機会
  • 主要成功戦略

第5章 リスク評価：COVID-19の影響

  • COVID-19が業界に与える全体的な影響の評価
  • COVID-19以前とCOVID-COVID-19以後の市場シナリオ

第6章 世界のin vivo CRO市場：タイプ別

  • 市場スナップショット
  • 世界のin vivo CRO市場実績－潜在分析：タイプ別
  • 世界のin vivo CRO市場の推定と予測（10億米ドル）（2018年～2028年）：タイプ別
  • in vivo CRO市場、サブセグメント分析
    • げっ歯類
    • 非げっ歯類

第7章 世界のin vivo CRO市場：GLPタイプ別

  • 市場スナップショット
  • 世界のin vivo CRO市場実績－潜在分析：GLPタイプ別
  • 世界のin vivo CRO市場の推定と予測（10億米ドル）（2018年～2028年）：GLPタイプ別
  • in vivo CRO市場、サブセグメント分析
    • 非GLP
    • GLPトキシコロジー

第8章 世界のin vivo CRO市場：適応症別

  • 市場スナップショット
  • 世界のin vivo CRO市場実績－潜在分析：適応症別
  • 世界のin vivo CRO市場の推定と予測（10億米ドル）（2018年～2028年）：適応症別
  • in vivo CRO市場、サブセグメント分析
    • 自己免疫/炎症状態
    • 疼痛管理
    • 腫瘍
    • CNS状態
    • 糖尿病
    • 肥満
    • その他

第9章 世界のin vivo CRO市場、地域分析

  • 地域の市場スナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他の欧州
  • アジア太平洋スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他のアジア太平洋
  • ラテンアメリカスナップショット
    • ブラジル
    • メキシコ
  • 世界のその他の地域

第10章 競合情報

  • 主要市場戦略
  • 企業プロファイル
    • Covance, Inc.
    • Theorem Clinical Research
    • WuXi AppTec, Inc.
    • inVentiv Health
    • Evotec(US), Inc.
    • Charles River Laboratories
    • American Preclinical Services, LLC.
    • GVK Biosciences Private Limited
    • Iris Pharma
    • Pronexus Analytical ABss

第11章 調査プロセス

図表

LIST OF TABLES

  • TABLE 1. Global In Vivo CRO Market, report scope
  • TABLE 2. Global In Vivo CRO Market estimates & forecasts by Region 2018-2028 (USD Billion)
  • TABLE 3. Global In Vivo CRO Market estimates & forecasts by Type 2018-2028 (USD Billion)
  • TABLE 4. Global In Vivo CRO Market estimates & forecasts by GLP Type 2018-2028 (USD Billion)
  • TABLE 5. Global In Vivo CRO Market estimates & forecasts by Indication 2018-2028 (USD Billion)
  • TABLE 6. Global In Vivo CRO Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 7. Global In Vivo CRO Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 8. Global In Vivo CRO Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 9. Global In Vivo CRO Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 10. Global In Vivo CRO Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 11. Global In Vivo CRO Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 12. Global In Vivo CRO Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 13. Global In Vivo CRO Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 14. Global In Vivo CRO Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 15. Global In Vivo CRO Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 16. U.S. In Vivo CRO Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 17. U.S. In Vivo CRO Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 18. U.S. In Vivo CRO Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 19. Canada In Vivo CRO Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 20. Canada In Vivo CRO Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 21. Canada In Vivo CRO Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 22. UK In Vivo CRO Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 23. UK In Vivo CRO Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 24. UK In Vivo CRO Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 25. Germany In Vivo CRO Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 26. Germany In Vivo CRO Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 27. Germany In Vivo CRO Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 28. RoE In Vivo CRO Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 29. RoE In Vivo CRO Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 30. RoE In Vivo CRO Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 31. China In Vivo CRO Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 32. China In Vivo CRO Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 33. China In Vivo CRO Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 34. India In Vivo CRO Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 35. India In Vivo CRO Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 36. India In Vivo CRO Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 37. Japan In Vivo CRO Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 38. Japan In Vivo CRO Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 39. Japan In Vivo CRO Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 40. RoAPAC In Vivo CRO Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 41. RoAPAC In Vivo CRO Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 42. RoAPAC In Vivo CRO Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 43. Brazil In Vivo CRO Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 44. Brazil In Vivo CRO Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 45. Brazil In Vivo CRO Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 46. Mexico In Vivo CRO Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 47. Mexico In Vivo CRO Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 48. Mexico In Vivo CRO Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 49. RoLA In Vivo CRO Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 50. RoLA In Vivo CRO Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 51. RoLA In Vivo CRO Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 52. Row In Vivo CRO Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 53. Row In Vivo CRO Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 54. Row In Vivo CRO Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 55. List of secondary sources, used in the study of global In Vivo CRO Market
  • TABLE 56. List of primary sources, used in the study of global In Vivo CRO Market
  • TABLE 57. Years considered for the study
  • TABLE 58. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global In Vivo CRO Market, research methodology
  • FIG 2. Global In Vivo CRO Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global In Vivo CRO Market, key trends 2021
  • FIG 5. Global In Vivo CRO Market, growth prospects 2022-2028
  • FIG 6. Global In Vivo CRO Market, porters 5 force model
  • FIG 7. Global In Vivo CRO Market, pest analysis
  • FIG 8. Global In Vivo CRO Market, value chain analysis
  • FIG 9. Global In Vivo CRO Market by segment, 2018 & 2028 (USD Billion)
  • FIG 10. Global In Vivo CRO Market by segment, 2018 & 2028 (USD Billion)
  • FIG 11. Global In Vivo CRO Market by segment, 2018 & 2028 (USD Billion)
  • FIG 12. Global In Vivo CRO Market by segment, 2018 & 2028 (USD Billion)
  • FIG 13. Global In Vivo CRO Market by segment, 2018 & 2028 (USD Billion)
  • FIG 14. Global In Vivo CRO Market, regional snapshot 2018 & 2028
  • FIG 15. North America In Vivo CRO Market 2018 & 2028 (USD Billion)
  • FIG 16. Europe In Vivo CRO Market 2018 & 2028 (USD Billion)
  • FIG 17. Asia pacific In Vivo CRO Market 2018 & 2028 (USD Billion)
  • FIG 18. Latin America In Vivo CRO Market 2018 & 2028 (USD Billion)
  • FIG 19. Global In Vivo CRO Market, company Market share analysis (2021)
目次

Global In Vivo CRO Market is valued approximately USD 3.9 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 8.20% over the forecast period 2022-2028. Contract research organizations (CROs) that conduct biopharmaceutical research in vivo are known as in-vivo contract research organizations (CROs). With the increased popularity of biologics over small molecule medications, in-vivo CROs are gaining appeal. Rising demand for sophisticated pharmaceuticals, CROs implementing worldwide standards, and big pharmaceutical firms outsourcing R&D efforts to focus more on their core capabilities are driving market expansion. Furthermore, outsourcing is less expensive than performing an in-house study. This is anticipated to increase demand for in vivo CROs. The demand for a significant number of animal models has quickly expanded across the world in order to ensure the safety and efficacy of novel entities prior to human trials. As a result, the use of these animal models in research centres, which closely resemble the clinical manifestation of SARS-CoV-2, has bolstered market growth. The most prevalent cause of insulin resistance is obesity. According to a National Center for Biotechnology Information (NCBI) research published in 2019, roughly 39% of individuals globally are obese or overweight and at risk of acquiring Type 2 Diabetes Mellitus (T2DM). T2DM is characterized by a gradual reduction in beta-cell activity and insulin resistance. The epidemic has created extraordinary interruption in research and clinical studies over the previous two years. The COVID-19 pandemic was claimed to have interrupted 1,079 clinical studies financed by sponsors, partners, or CROs in November 2021. As of June 2021, oncology was the most affected therapeutic area, accounting for approximately a quarter of all interrupted studies. Clinical trial interruptions would have an influence on the in vivo studies industry. However, sponsors raised CRO outsourced trial spending in 2021 compared to the previous year, according to a recent Outsourcing-Pharma study. The majority of investments are going toward enhancing CRO assistance, particularly technology-based solutions to increase patient access and engagement. Furthermore, a rise in M&A activity by big and mid-sized CROs in 2021 would have a significant post-COVID-19 influence on market growth. Sygnature Discovery, for example, was sold to Rothschild's private equity arm, Five Arrows Principal Investment, and later to Keensight. This illustrates the enthusiasm of investors to invest in early-stage R&D CROs. Furthermore, a rise in M&A activity by big and mid-sized CROs in 2021 would have a significant post-COVID-19 influence on market growth. However, pharmaceutical companies' shifting preference for outsourcing clinical and preclinical trials impedes the growth of the market over the forecast period of 2022-2028.

The key regions considered for the Global In Vivo CRO Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America emerged as the market leader. The existence of significant financing in this region influenced research efforts positively. For example, the United States has the largest per capita healthcare spending and funding from government agencies such as the National Institutes of Health (NIH), which promotes research. Over the projection period, Asia Pacific is expected to have the quickest CAGR. The region has a sizable treatment-naive population. It accounts for 53% of the world's urban population and has three times the yearly rate of urbanization as the West. These reasons are driving increase in clinical trials in Asia Pacific.

Major market players included in this report are:

Covance, Inc.

Theorem Clinical Research

WuXi AppTec, Inc.

inVentiv Health

Evotec (US), Inc.

Charles River Laboratories

American Preclinical Services, LLC.

GVK Biosciences Private Limited

Iris Pharma

Pronexus Analytical AB

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

Rodent

Non-Rodent

By GLP Type:

Non-GLP

GLP Toxicology

By Indication:

Autoimmune/Inflammation Conditions

Pain Management

Oncology

CNS Conditions

Diabetes

Obesity

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global In Vivo CRO Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
    • 1.2.1. In Vivo CRO Market, by Region, 2020-2028 (USD Billion)
    • 1.2.2. In Vivo CRO Market, by Type, 2020-2028 (USD Billion)
    • 1.2.3. In Vivo CRO Market, by GLP Type, 2020-2028 (USD Billion)
    • 1.2.4. In Vivo CRO Market, by Indication, 2020-2028 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global In Vivo CRO Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global In Vivo CRO Market Dynamics

  • 3.1. In Vivo CRO Market Impact Analysis (2020-2028)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Implementation of international standards by CROs
      • 3.1.1.2. Rise in outsourcing of R&D activities by major pharmaceutical companies
    • 3.1.2. Market Challenges
      • 3.1.2.1. pharmaceutical companies' shifting preference for outsourcing clinical and preclinical trials
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Technological improvements in In Vivo CRO

Chapter 4. Global In Vivo CRO Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion
  • 4.5. Top investment opportunity
  • 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

    • 5.1.1. Assessment of the overall impact of COVID-19 on the industry
    • 5.1.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global In Vivo CRO Market, by Type

  • 6.1. Market Snapshot
  • 6.2. Global In Vivo CRO Market by Type, Performance - Potential Analysis
  • 6.3. Global In Vivo CRO Market Estimates & Forecasts by Type 2018-2028 (USD Billion)
  • 6.4. In Vivo CRO Market, Sub Segment Analysis
    • 6.4.1. Rodent
    • 6.4.2. Non-Rodent

Chapter 7. Global In Vivo CRO Market, by GLP Type

  • 7.1. Market Snapshot
  • 7.2. Global In Vivo CRO Market by GLP Type, Performance - Potential Analysis
  • 7.3. Global In Vivo CRO Market Estimates & Forecasts by GLP Type 2018-2028 (USD Billion)
  • 7.4. In Vivo CRO Market, Sub Segment Analysis
    • 7.4.1. Non-GLP
    • 7.4.2. GLP Toxicology

Chapter 8. Global In Vivo CRO Market, by Indication

  • 8.1. Market Snapshot
  • 8.2. Global In Vivo CRO Market by Indication, Performance - Potential Analysis
  • 8.3. Global In Vivo CRO Market Estimates & Forecasts by Indication 2018-2028 (USD Billion)
  • 8.4. In Vivo CRO Market, Sub Segment Analysis
    • 8.4.1. Autoimmune/Inflammation Conditions
    • 8.4.2. Pain Management
    • 8.4.3. Oncology
    • 8.4.4. CNS Conditions
    • 8.4.5. Diabetes
    • 8.4.6. Obesity
    • 8.4.7. Others

Chapter 9. Global In Vivo CRO Market, Regional Analysis

  • 9.1. In Vivo CRO Market, Regional Market Snapshot
  • 9.2. North America In Vivo CRO Market
    • 9.2.1. U.S. In Vivo CRO Market
      • 9.2.1.1. Type breakdown estimates & forecasts, 2018-2028
      • 9.2.1.2. GLP Type breakdown estimates & forecasts, 2018-2028
      • 9.2.1.3. Indication breakdown estimates & forecasts, 2018-2028
    • 9.2.2. Canada In Vivo CRO Market
  • 9.3. Europe In Vivo CRO Market Snapshot
    • 9.3.1. U.K. In Vivo CRO Market
    • 9.3.2. Germany In Vivo CRO Market
    • 9.3.3. France In Vivo CRO Market
    • 9.3.4. Spain In Vivo CRO Market
    • 9.3.5. Italy In Vivo CRO Market
    • 9.3.6. Rest of Europe In Vivo CRO Market
  • 9.4. Asia-Pacific In Vivo CRO Market Snapshot
    • 9.4.1. China In Vivo CRO Market
    • 9.4.2. India In Vivo CRO Market
    • 9.4.3. Japan In Vivo CRO Market
    • 9.4.4. Australia In Vivo CRO Market
    • 9.4.5. South Korea In Vivo CRO Market
    • 9.4.6. Rest of Asia Pacific In Vivo CRO Market
  • 9.5. Latin America In Vivo CRO Market Snapshot
    • 9.5.1. Brazil In Vivo CRO Market
    • 9.5.2. Mexico In Vivo CRO Market
  • 9.6. Rest of The World In Vivo CRO Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Covance, Inc.
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Type Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Theorem Clinical Research
    • 10.2.3. WuXi AppTec, Inc.
    • 10.2.4. inVentiv Health
    • 10.2.5. Evotec (US), Inc.
    • 10.2.6. Charles River Laboratories
    • 10.2.7. American Preclinical Services, LLC.
    • 10.2.8. GVK Biosciences Private Limited
    • 10.2.9. Iris Pharma
    • 10.2.10. Pronexus Analytical ABss

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption